Native Clostridium difficile Toxin B protein
5
(1 Review)
|
(9 Publications)
Native Clostridium difficile Toxin B protein is a Clostridium difficile (strain VPI10463) Full Length protein in the 2 to 2366 aa range with >95% purity and suitable for SDS-PAGE and Functional studies. The predicted molecular weight of ab124001 native protein is 270 kDa.
- Save time and ensure accurate results - use our Clostridium difficile Toxin B as a control
- Optimal protein bioactivity and stability
View Alternative Names
toxB, tcdB, Toxin B
- SDS-PAGE
Unknown
SDS-PAGE - Native Clostridium difficile Toxin B protein (AB124001)
SDS-PAGE showing ab124001 at 270 kDa.
Reactivity data
Product details
The Native Clostridium difficile Toxin B protein ab124001 is derived from a pathogenic organism, and may be involved in a disease process, consequently exposure may have adverse health effects.
This product is an active protein and may elicit a biological response in vivo, handle with caution.
Ensure the validity of your result using our native Clostridium difficile Toxin B protein ab124001 as a positive control in SDS-PAGE.
Check out our protein gel staining guide for SDS-PAGE here
Functional Studies Protocol
1.1 Vero cells are plated out the night before on a 96-well plate at a concentration of 20K cells per well (in 100 ml), then incubated at 37°C, 5% CO2. The following day they should be lightly confluent.
1.2 Lyophilised toxin/toxoid is resuspended as per the instructions in the certificate of analysis, and diluted in duplicate to 0.1 mg/ml in DMEM (200 ml total) without FBS in the first well of a non-TC-treated 96-well plate. A serial 5-fold dilution is performed (40µl in 160 µl) in the same media using a multichannel for 11 dilutions in total, leaving the 12th dilution as a media control.
1.3 20 µl of each dilution is then pipetted onto each well of the pre-prepared Vero cells and then incubated at 37°C, 5% CO2 for 24 hours.
1.4 The following day, the cells are examined using an inverted phase contrast tissue culture microscope. Cells with active toxin on should be rounded, cells without significant toxicity should look like the control cells.
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This toxin exerts its effects by modifying intracellular signaling pathways disrupting tight junctions and leading to cell apoptosis. Toxin B specifically targets the Rho family of GTPases through glucosylation leading to actin cytoskeleton disorganization and subsequent cell rounding and tissue damage. It functions independently but works in conjunction with Toxin A to enhance virulence. As part of its biological role Toxin B proves essential in the pathogenesis of diseases associated with C. diff infection.
Pathways
Research shows Toxin B's involvement in the disruption of the actin cytoskeleton pathway. This pathway alteration results from direct modification of small GTP-binding proteins such as RhoA Rac and Cdc42. Toxin B's activity leads to loss of cell structure and increased cell lysis showcasing how it fits into major cellular integrity pathways. Its interaction with these proteins places it alongside other microbial toxins that manipulate host cell signaling.
Specifications
Form
Lyophilized
Additional notes
Clostridium difficile Toxin B has been highly purified.
General info
Function
Toxin B. Precursor of a cytotoxin that targets and disrupts the colonic epithelium, inducing the host inflammatory and innate immune responses and resulting in diarrhea and pseudomembranous colitis (PubMed : 20844489, PubMed : 24919149). TcdB constitutes the main toxin that mediates the pathology of C.difficile infection, an opportunistic pathogen that colonizes the colon when the normal gut microbiome is disrupted (PubMed : 19252482, PubMed : 20844489). Compared to TcdA, TcdB is more virulent and more important for inducing the host inflammatory and innate immune responses (PubMed : 19252482, PubMed : 24919149). This form constitutes the precursor of the toxin : it enters into host cells and mediates autoprocessing to release the active toxin (Glucosyltransferase TcdB) into the host cytosol (PubMed : 10768933, PubMed : 11152463, PubMed : 12941936, PubMed : 17334356, PubMed : 20498856). Targets colonic epithelia by binding to the frizzled receptors FZD1, FZD2 and FZD7, and enters host cells via clathrin-mediated endocytosis (PubMed : 27680706). Frizzled receptors constitute the major host receptors in the colonic epithelium, but other receptors, such as CSPG4 or NECTIN3/PVRL3, have been identified (PubMed : 25547119, PubMed : 26038560, PubMed : 27680706). Binding to carbohydrates and sulfated glycosaminoglycans on host cell surface also contribute to entry into cells (By similarity). Once entered into host cells, acidification in the endosome promotes the membrane insertion of the translocation region and formation of a pore, leading to translocation of the GT44 and peptidase C80 domains across the endosomal membrane (PubMed : 11152463, PubMed : 12941936, PubMed : 24567384). This activates the peptidase C80 domain and autocatalytic processing, releasing the N-terminal part (Glucosyltransferase TcdB), which constitutes the active part of the toxin, in the cytosol (PubMed : 17334356, PubMed : 27571750).. Glucosyltransferase TcdB. Active form of the toxin, which is released into the host cytosol following autoprocessing and inactivates small GTPases (PubMed : 16157585, PubMed : 17901056, PubMed : 24905543, PubMed : 24919149, PubMed : 7777059, PubMed : 8144660). Acts by mediating monoglucosylation of small GTPases of the Rho family (Rac1, RhoA, RhoB, RhoC, RhoG and Cdc42) in host cells at the conserved threonine residue located in the switch I region ('Thr-37/35'), using UDP-alpha-D-glucose as the sugar donor (PubMed : 16157585, PubMed : 17901056, PubMed : 24905543, PubMed : 24919149, PubMed : 7777059). Monoglucosylation of host small GTPases completely prevents the recognition of the downstream effector, blocking the GTPases in their inactive form, leading to actin cytoskeleton disruption and cell death, resulting in the loss of colonic epithelial barrier function (PubMed : 24919149, PubMed : 7777059).
Sequence similarities
Belongs to the clostridial glucosylating toxin (LCGT) family.
Post-translational modifications
Toxin B. Undergoes autocatalytic cleavage to release the N-terminal part (Glucosyltransferase TcdB), which constitutes the active part of the toxin, in the host cytosol (PubMed:12941936, PubMed:17334356, PubMed:27571750). 1D-myo-inositol hexakisphosphate-binding (InsP6) activates the peptidase C80 domain and promotes autoprocessing (PubMed:17334356).
Subcellular localisation
Host endosome membrane
Target data
Publications (9)
Recent publications for all applications. Explore the full list and refine your search
Gut microbes 17:2506192 PubMed40383912
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature immunology 26:511-523 PubMed39930093
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 41:111472 PubMed36223753
2022
Applications
Unspecified application
Species
Unspecified reactive species
Methods in molecular biology (Clifton, N.J.) 2523:179-195 PubMed35759198
2022
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of experimental medicine 218: PubMed34342641
2021
Applications
Unspecified application
Species
Unspecified reactive species
EMBO molecular medicine 11:e10547 PubMed31589380
2019
Applications
Unspecified application
Species
Unspecified reactive species
Infection and immunity 87: PubMed30530621
2018
Applications
Unspecified application
Species
Unspecified reactive species
Annals of the rheumatic diseases 76:2085-2094 PubMed28835462
2017
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 7:3665 PubMed28623367
2017
Applications
Neut
Species
Clostridium difficile
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com